Videos Library
Panel Discussion: MedTech industry perspectives on value demonstration with payers, procurers & customers
Related topics:
MedTech, USA, Market Access & HEOR
Overview
- How successful is industry in communicating Health economic benefits to Payers & how receptive are they to these forms of evidence?
- Linking health economic benefits to the tendering process: How can manufacturers make their products stand out in a competitive acquisition process?
- What level of clinical evidence is sufficient to achieve access for different device types & life cycles?
- How does the industry want customers to prioritize innovative products to enhance clinical standards?
- How can industry ensure distributors are effectively utilizing the“value proposition” in the field?
Panelists
DeChane Dorsey
Vice President, Payment and Health Care Delivery Policy
AdvaMed
Van Crocker
President of Healthgen Outcomes
Aetna
Philip Macdonald
Vice President, Healthcare Economics, Policy & Reimbursement
EndoGastric Solutions
Rob Wenthold
Vice President
Boston Healthcare Associates
Brian Holt
Chief Innovation Officer
IPG, USA
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.